Abstract |
CCR5-tropic (R5) immunodeficiency virus type 1 (HIV-1) strains are highly transmissible during the early stage of infection in humans, whereas CXCR4-tropic (X4) strains are less transmissible. This study aimed to explore the basis for early phase R5 and X4 HIV-1 infection in vivo by using humanized mice dually challenged with R5 HIV-1NLAD8-D harboring DsRed and X4 HIV-1(NL-E) harboring EGFP. Whereas R5 HIV-1 replicated well, X4 HIV-1 caused only transient viremia with variable kinetics; however, this was distinct from the low level but persistent viremia observed in mice challenged with X4 HIV-1 alone. Flow cytometric analysis of HIV-1-infected cells revealed that X4 HIV-1 infection of CCR5(+)CD4(+) T cells was significantly suppressed in the presence of R5 HIV-1. X4 HIV-1 was more cytopathic than R5 HIV-1; however, this was not the cause of restricted X4 HIV-1 infection because there were no significant differences in the mortality rates of CCR5(+) and CCR5(-) cells within the X4 HIV-1-infected cell populations. Taken together, these results suggest that restricted infection of CCR5(+)CD4(+) T cells by X4 HIV-1 (occurring via a still-to-be-identified mechanism) might contribute to the preferential transmission of R5 HIV-1 during the early phase of infection.
|
Authors | Kazutaka Terahara, Masayuki Ishige, Shota Ikeno, Seiji Okada, Mie Kobayashi-Ishihara, Manabu Ato, Yasuko Tsunetsugu-Yokota |
Journal | Microbes and infection
(Microbes Infect)
Vol. 17
Issue 5
Pg. 378-86
(May 2015)
ISSN: 1769-714X [Electronic] France |
PMID | 25839960
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Receptors, CCR5
- Receptors, CXCR4
|
Topics |
- Animals
- CD4-Positive T-Lymphocytes
(cytology, virology)
- HIV-1
(immunology, pathogenicity)
- Mice
- Receptors, CCR5
(immunology)
- Receptors, CXCR4
(immunology)
- Viremia
(mortality, pathology, transmission)
- Virus Replication
(immunology)
|